WallStreetZenWallStreetZen

NASDAQ: SNTI
Senti Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their SNTI stock forecasts and price targets.

Forecast return on equity

Is SNTI forecast to generate an efficient return?

Forecast return on assets

Is SNTI forecast to generate an efficient return on assets?

SNTI revenue forecast

What is SNTI's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.8M+48.38%
Avg 2 year Forecast
$23.6M+823.08%
SNTI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SNTI revenue growth forecast

How is SNTI forecast to perform vs Biotechnology companies and vs the US market?
Company
48.38%
Industry
247.64%
Market
13.29%
SNTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SNTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SNTI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SNTI$0.28N/AN/A
COEP$0.36N/AN/A
KPRX$0.49$2.00+312.37%Buy
MIRA$0.86N/AN/A
AVTX$12.21$35.00+186.65%Buy
View Top Biotech Stocks

Senti Biosciences Stock Forecast FAQ

What is SNTI's revenue growth forecast for 2024-2025?

(NASDAQ: SNTI) Senti Biosciences's forecast annual revenue growth rate of 48.38% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 247.64%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.29%.

Senti Biosciences's revenue in 2024 is $2,561,000.On average, 1 Wall Street analysts forecast SNTI's revenue for 2024 to be $173,869,080, with the lowest SNTI revenue forecast at $173,869,080, and the highest SNTI revenue forecast at $173,869,080.

In 2025, SNTI is forecast to generate $1,081,648,696 in revenue, with the lowest revenue forecast at $1,081,648,696 and the highest revenue forecast at $1,081,648,696.

If you're new to stock investing, here's how to buy Senti Biosciences stock.

What is SNTI's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: SNTI) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 28.47%.

What is SNTI's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: SNTI) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.